Gudrun Schiedner

Heidelberg Pharma (Germany) — Germany

Biochemistry, Genetics and Molecular Biology · Life Sciences

20h-index2.8kcitations47works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Virus-based gene therapy research(38), Viral Infectious Diseases and Gene Expression in Insects(26), RNA Interference and Gene Delivery(12), CAR-T cell therapy research(8), Viral gastroenteritis research and epidemiology(7)

Publications47 total

A First in Human Study Planned to Evaluate Hdp-101, an Anti-BCMA Amanitin Antibody-Drug Conjugate with a New Payload and a New Mode of Action, in Multiple Myeloma
Blood·2020· 12 cited
Adenovirus E1A/E1B Transformed Amniotic Fluid Cells Support Human Cytomegalovirus Replication
Viruses·2016· 13 citedOpen Access
High cell density cultivations by alternating tangential flow (ATF) perfusion for influenza A virus production using suspension cells
Vaccine·2014· 99 cited
Identifying & Isolating High-Producer Clones
Genetic Engineering & Biotechnology News·2013
CAP, a new human suspension cell line for influenza virus production
Applied Microbiology and Biotechnology·2012· 42 cited
Transient recombinant protein expression in a human amniocyte cell line: The CAP‐T® cell system
Biotechnology and Bioengineering·2012· 49 cited
Cell culture-based influenza virus production: suspension or adherent producer cell lines?
Max Planck Institute for Plasma Physics·2012
High cell density cultivations for influenza virus production using suspension cells
Max Planck Institute for Plasma Physics·2012· 1 cited
Improving volumetric productivity of a stable human CAP cell line by bioprocess optimization
BMC Proceedings·2011· 10 citedOpen Access
CAP-T cell expression system: a novel rapid and versatile human cell expression system for fast and high yield transient protein expression
BMC Proceedings·2011· 9 citedOpen Access
Very High Protein Production Levels with a New Transient and Serum-Free Expression System Based on Human CAP Cells
2011· 1 cited
Development of a Biphasic Culture Process for Recombinant Protein Production in Human CAP Cells
2011
CAP Technology: Production of Influenza Vaccine in Human Amniocytes
Max Planck Institute for Plasma Physics·2011
Influenza virus production: characteristics of different producer cell lines
Max Planck Institute for Plasma Physics·2011
Genomic integration of adenoviral gene transfer vectors following transduction of fertilized mouse oocytes
Transgenic Research·2010· 4 cited
Human Cell Lines for Production of Biopharmaceuticals
2010· 4 cited
Efficient and reproducible generation of high-expressing, stable human cell lines without need for antibiotic selection
BMC Biotechnology·2008· 48 citedOpen Access
Production and Quality Control of High-Capacity Adenoviral Vectors
Cell Biology·2006· 2 cited
Transduction of antigen-presenting cells using viral vectors: a double edge sword
2005
Sustained Muscle Expression of Dystrophin from a High-Capacity Adenoviral Vector with Systemic Gene Transfer of T Cell Costimulatory Blockade
Molecular Therapy·2004· 31 citedOpen Access
page 1 of 3Next →

Frequent Co-authors

Stefan Kochanek(26), Sabine Hertel(11), Marinee Chuah(7), Lieven Thorrez(7), Thierry VandenDriessche(7), Yvonne Genzel(6), Ilona Behrendt(6), Udo Reichl(6), N Van Rooijen(6), David Lillicrap(5), Helmut Kewes(5), Marion M. Johnston(4), Volker Dries(4), Nico van Rooijen(4), Désiré Collen(4), Christoph Volpers(4), Ingo Jordan(4), Corinna Bialek(4), Ruth Essers(4), Brian D. Brown(3)